Last reviewed · How we verify

NCT06079021: COOLEY

COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device

Recruiting now NA Last updated 10 December 2024
What this trial tests

NA trial testing CytoSorb in Acute-On-Chronic Liver Failure in 20 participants. Currently enrolling.

Timeline
8 June 2024
Primary endpoint
30 September 2026
30 September 2027

Quick facts

Lead sponsorUniversity Hospital, Antwerp
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date8 June 2024
Primary completion30 September 2026
Estimated completion30 September 2027
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Antwerp

Who can join

18 and older, any sex, with Acute-On-Chronic Liver Failure or Anticoagulant Adverse Reaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Prospective, Single-Center trial, in Patients With Acute on Chronic Liver Failure. Study of Standard Medical Care Plus CytoSorb® Compared to Standard Medical Care Alone in a historical group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The use of CytoSorb hemoadsorption in critically ill patients: a narrative review.
    Lei K, Chen A, An X, Guo J, et al · · 2025 · cited 1× · PMID 41058625 · DOI 10.3389/fmed.2025.1628241

Verify or expand the search:

Other trials of CytoSorb

Trials testing the same drug.

Other recruiting trials for Acute-On-Chronic Liver Failure

Currently open trials in the same condition.

Other University Hospital, Antwerp trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06079021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing